Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: 3rd dose (booster) - Sore arm; fatigue; fever; chills; body aches; naseau; large red swollen area right below injection spot; large red swollen area right below injection spot/ The swollen area is hard, red warm and itchy; The swollen area is hard, red warm and itchy; The swollen area is hard, red warm and itchy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Nov2021 14:30 (Lot number: FF2590) at the age of 48 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing); "Hashimoto" (unspecified if ongoing); "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE [LEVOTHYROXINE SODIUM]; VITRON-C; BUPROPION HCL XL; LAMOTRIGINE; FLU, administration date 29Oct2021. Vaccination history included: Bnt162b2 (prev dose vaccine location=left },{ prev dose product=Covid-19, ,prev dose brand=Pfizer, prev dose brand unknown=False ,prev dose lot number=ER8727 ,prev dose lot unknown=False ,prev dose administration date=18Mar2021 ,prev dose administration time-04:30 PM , Prev dose dose number=1), administration date: 18Mar2021, when the patient was 48 years old, for Covid-19 immunization, reaction(s): "Sore arm"; Bnt162b2 (prev dose brand-Pfizer- Covid-19, prev dose brand=pfizer, prev dose brand prev dose brand-Pfizer- Covid-19, prev dose brand=pfizer, prev dose brand unknown=False , prev dose lot number=ER8729 ,prev dose lot unknown=False , prev dose administration date-08Apr2021 ,prev dose administration time =04:30 PM, prev dose number 2 , prev dose vaccine location=left arm), administration date: 08Apr2021, when the patient was 48 years old, for Covid-19 immunization, reaction(s): "Sore arm", "Fatigue", "Fever", "Body ache"; Bnt162b2 (prev dose brand-Pfizer- Covid-19, prev dose brand=pfizer, prev dose brand unknown=False , prev dose lot number=ER8729 ,prev dose lot unknown=False , prev dose administration date-08Apr2021,prev dose administration time =04:30 PM, prev dose number 2 , prev dose vaccine location=left arm), administration date: 08Apr2021, when the patient was 48 years old, for Covid-19 Immunization, reaction(s): "chills". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "3rd dose (booster) - Sore arm"; FATIGUE (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "fatigue"; PYREXIA (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "fever"; CHILLS (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "chills"; PAIN (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "body aches"; NAUSEA (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "naseau"; VACCINATION SITE SWELLING (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "large red swollen area right below injection spot"; VACCINATION SITE ERYTHEMA (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "large red swollen area right below injection spot/ The swollen area is hard, red warm and itchy"; VACCINATION SITE WARMTH (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 14Nov2021 02:00, outcome "recovering" and all described as "The swollen area is hard, red warm and itchy". Therapeutic measures were not taken as a result of pain in extremity, fatigue, pyrexia, chills, pain, nausea, vaccination site swelling, vaccination site erythema, vaccination site warmth, vaccination site pruritus.  Additional information: Other vaccine in four weeks included Flu. Other medications in two weeks included Vitron-C, Levothyroxin , Bupropion XL, Lamotrigine. Ae resulted in none. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any treatment for the event.  No follow-up attempts are possible. No further information is expected.